Johnson & Johnson (JNJ) and Elan Corporation plc (ELN) Announce Closing of Transaction Related to Alzheimer's Immunotherapy Program and Equity Investment

September 17, 2009 9:13 AM EDT Send to a Friend
Johnson & Johnson (NYSE: JNJ) and Elan Corporation plc (NYSE: ELN) announced that JANSSEN Alzheimer Immunotherapy, a newly formed subsidiary ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login